VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on advancing its wholly owned and permitted South Crofty tin project in Cornwall, United Kingdom, is pleased to announce that on 29 July 2025, the Company hosted The RT Hon Rachel Reeves MP, Chancellor of the Exchequer, at South Crofty. This visit follows the UK Government’s £28.6 million investment in Q1-2025 via the ...

Wolters Kluwer 2025 Half-Year Report Alphen aan den Rijn, July 30, 2025 – Wolters Kluwer, a global leader in professional information solutions, software and services, today releases its half-year 2025 results. Highlights Guidance for 2025 updated. (See page 2).Revenues €3,052 million, up 6% in constant currencies and up 5% organically. Recurring revenues (84% of total) grew 7% organically; non-recurring declined 4% organically.Expert solutions (59% of total) grew 6% organically.Recurring cloud software (21 ...

Press Release – Paris, July 30, 2025, at 7:45 AM CEST Notification of availability of Danone’s 2025 interim financial report Danone today releases its half-year financial report as of June 30, 2025, now available online on its website (link). About Danone (www.danone.com) Danone is a leading global food and beverage company operating in three health-focused, fast-growing and on-trend Categories: Essential Dairy & Plant-Based products, Waters and Specialized Nutrition. With a long-standing mission of bringin ...

I am a dynamic finance professional with a Master’s in Banking & Finance from Université Paris 1 Panthéon-Sorbonne. My investing background mix corporate finance, M&A, and investment analysis, with a focus on real estate, renewable energy, and equity markets. I specialize in financial modelling, valuation, and qualitative analysis, demonstrated with hands-on roles in private equity, asset management and Real Estate. On Seeking Alpha, I aim to write about companies I find interesting sharing my insights and ...

2025 Half-Year ResultsPress release – Paris, July 30, 2025 at 7:30am CEST A strong first halfConsistently delivering quality results H1 2025 sales of €13,737m up +4.2% on a like-for-like (LFL) basis, with volume/mix up +2.6%, and price up +1.7%Q2 sales up +4.1% LFL, with strong volume/mix of +3.2%, and positive price of +1.0%Recurring operating margin up +49 bps to 13.2% driven by further expansion in margin from operationsRecurring EPS up +5.8% to €1.91, driven by operational performanceFree cash flow at ...

More information is available on Aedifica’s website via the link below and can be accessed subject to the usual restrictions. Press release ENCommuniqué de presse FRPersbericht NL ... Read More ...

Sanofi's SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma Designation granted for IgG1-based GPRC5D monoclonal antibody for the potential treatment of patients with relapsed or refractory multiple myeloma For more information on MM clinical studies, please visit www.clinicaltrials.gov. About Sanofi Sanofi is an R&D driven, AI-powered biopharma company committed to improving people's lives and delivering compelling growth. We apply our deep understanding o ...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 30, 2025 Idorsia Ltd (SIX: IDIA) today published its Financial Report for the first half of 2025. The results confirm that the commercial acceleration of QUVIVIQ coupled with the financial discipline implemented over the past 12 months have successfully delivered an operational turn-around. The company is on track to reach its target of overall profitability starting from the end of 2027. Srishti Gupta, MD, Chief Executive Officer of I ...

The Netherlands, 30 July 2025 Vopak reports strong HY1 2025 results driven by a resilient portfolio and is increasing FY 2025 outlook Key highlights HY1 2025 Improve Grow Accelerate | Q2 | Q1 | Q2 | In EUR millions | HY1 | HY1 | | --- | --- | --- | --- | --- | --- | | 2025 | 2025 | 2024 | | 2025 | 2024 | | | | | IFRS Measures -including exceptional items | | | | 322.6 | 328.9 | 325.5 | Revenues | 651.5 | 653.7 | | 218.8 | 99.8 | 106.7 | Net profit / (loss) attributable to holders of ordinary shares | 318.6 ...

Novocure Limited (NASDAQ: NVCR ) develops wearables that generate Tumor Treating Fields (TTFields), which can be used for treating aggressive cancers. In that sense, NVCR features approved devices like Optune and Optune Gio for treating glioblastoma (GBM). NVCR’s Optune Lua instead helpsMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athen ...